Zonisamide - induced urinary lithiasis in patients with intractable epilepsy

被引:40
|
作者
Kubota, M
Nishi-Nagase, M
Sakakihara, Y
Noma, S
Nakamoto, M
Kawaguchi, H
Yanagisawa, M
机构
[1] Univ Tokyo, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan
[2] Metropolitan Hachiouji Childrens Hosp, Dept Pediat, Tokyo, Japan
来源
BRAIN & DEVELOPMENT | 2000年 / 22卷 / 04期
关键词
zonisamide; urinary lithiasis; epilepsy;
D O I
10.1016/S0387-7604(00)00118-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report here three patients with intractable epilepsy who developed urinary lithiasis during zonisamide (ZNS) treatment. Abdominal pain due to left-sided hydronephrosis was the initial symptom in the first patient, and it was resolved after the excretion of a stone. The second patient, who had no specific symptoms, was found to have a thick: sludge of calcium phosphate: in the bladder when he suffered from aspiration pneumonia and dehydration. The third patient, who had a history of recurrent urinary obstruction, was also found to have a thick sludge of calcium oxalate in the bladder. The urinalysis of the three patients revealed alkaline urine and hypercalciuria. Although their urinary lithiasis was resolved by discontinuation of ZNS and supportive therapy, routine examination of urine parameters such as pn and sediments, and daily urine-output cheeks are thought to be necessary during treatment with ZNS, especially for patients who are bedridden tor a long time and receive multiple antiepileptic drugs. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:230 / 233
页数:4
相关论文
共 50 条
  • [1] EFFICACY OF ZONISAMIDE FOR INTRACTABLE EPILEPSY IN CHILDHOOD
    TAKAHASHI, I
    NOMURA, K
    YAMAMOTO, N
    FURUNE, S
    ASO, K
    TAKAESU, E
    NEGORO, T
    WATANABE, K
    MATSUMOTO, A
    TAKEUCHI, T
    HAKAMADA, S
    HAYAKAWA, F
    MAEHARA, M
    BRAIN & DEVELOPMENT, 1987, 9 (02): : 157 - 157
  • [2] Retention rate of zonisamide in intractable epilepsy
    Nakken, K. O.
    Lindstrom, P.
    Andersen, H.
    ACTA NEUROLOGICA SCANDINAVICA, 2015, 131 (05): : 268 - 274
  • [3] Antiepileptic effect of zonisamide in paediatric intractable epilepsy
    Ko, T.
    Yum, M.
    You, S.
    EPILEPSIA, 2006, 47 : 173 - 174
  • [4] Clinical experience with Levetiracetam and Zonisamide in children with intractable epilepsy
    Mandelbaum, DE
    Kugler, SL
    Wenger, EC
    Wollack, JB
    Venkat, A
    NEUROLOGY, 2001, 56 (08) : A46 - A46
  • [5] Zonisamide-induced depression and mania in patients with epilepsy
    Ozawa, K
    Kobayashi, K
    Noda, S
    Iyo, M
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (01) : 110 - 111
  • [6] Tolerability and efficacy of zonisamide in intractable epilepsy. A Spanish epilepsy unit experience
    Ojeda, J.
    Ivanez, V.
    JOURNAL OF NEUROLOGY, 2007, 254 : 127 - 127
  • [7] Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy
    Lee, Yun Jin
    Kang, Hoon Chul
    Seo, Joo Hee
    Lee, Joon Soo
    Kim, Heung Dong
    BRAIN & DEVELOPMENT, 2010, 32 (03): : 208 - 212
  • [8] URINARY INFECTIONS IN PATIENTS WITH LITHIASIS
    PETKOVIC, S
    OSTOJIC, B
    JOURNAL D UROLOGIE, 1982, 88 (10) : 679 - 680
  • [9] Broad-spectrum efficacy of zonisamide at 12 months in children with intractable epilepsy
    Mandelbaum, DE
    Bunch, M
    Kugler, SL
    Venkatasubramanian, A
    Wollack, JB
    JOURNAL OF CHILD NEUROLOGY, 2005, 20 (07) : 594 - 597
  • [10] Zonisamide dosing in pediatric patients with epilepsy
    Wyllie, E
    Pellock, JM
    NEUROLOGY, 1999, 52 (06) : A238 - A238